Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Feld

Showing results (261-270 of 451) with videos related to

Pageof 46
Sort By:
Canadian Liver Journal|July 28, 2023
Province-to-province variability in hepatitis C testing, care, and treatment across CanadaErin Mandel, Kate Underwood, Chelsea Masterman, et al.
Hepatology (Baltimore, Md.)|July 17, 2019
Nonalcoholic Steatohepatitis Is Associated With Liver-Related Outcomes and All-Cause Mortality in Chronic Hepatitis BHannah S J Choi, Willem P Brouwer, Wayel M R Zanjir, et al.
The Lancet. Gastroenterology & Hepatology|April 19, 2017
Ombitasvir, paritaprevir, and ritonavir plus dasabuvir for 8 weeks in previously untreated patients with hepatitis C virus genotype 1b infection without cirrhosis (GARNET): a single-arm, open-label, phase 3b trialTania M Welzel, Tarik Asselah, Emily O Dumas, et al.
Gastroenterology|September 15, 2009
Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent mannerGolo Ahlenstiel, Rachel H Titerence, Christopher Koh, et al.
Scientific Reports|October 29, 2025
Novel and less invasive biomarker assays to measure liver ATP7B in Wilson disease patientsRosanna J Jiang, Lucy Chen, Kimberly Amburgey, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 27, 2019
Prevalence and predictors of complementary and alternative medicine modalities in patients with chronic hepatitis BKin Seng Liem, Colina Yim, Thomas D Ying, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 13, 2015
Hepatitis B Virus Screening for Patients With Cancer Before Therapy: American Society of Clinical Oncology Provisional Clinical Opinion UpdateJessica P Hwang, Mark R Somerfield, Devena E Alston-Johnson, et al.
Hepatology (Baltimore, Md.)|October 12, 2007
Hepatic gene expression during treatment with peginterferon and ribavirin: Identifying molecular pathways for treatment responseJordan J Feld, Santosh Nanda, Ying Huang, et al.
Virology Journal|February 26, 2016
Alanine aminotransferase, HCV RNA levels and pro-inflammatory and pro-fibrogenic cytokines/chemokines during acute hepatitis C virus infectionBehzad Hajarizadeh, François Mj Lamoury, Jordan J Feld, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 17, 2022
Characteristics of Older Patients With Immunotolerant Chronic Hepatitis B Virus InfectionJordan J Feld, Wendy C King, Marc G Ghany, et al.
Pageof 46

Showing results (261-270 of 451) with videos related to

Sort By:
Pageof 46
Canadian Liver Journal|July 28, 2023
Province-to-province variability in hepatitis C testing, care, and treatment across CanadaErin Mandel, Kate Underwood, Chelsea Masterman, et al.
Hepatology (Baltimore, Md.)|July 17, 2019
Nonalcoholic Steatohepatitis Is Associated With Liver-Related Outcomes and All-Cause Mortality in Chronic Hepatitis BHannah S J Choi, Willem P Brouwer, Wayel M R Zanjir, et al.
The Lancet. Gastroenterology & Hepatology|April 19, 2017
Ombitasvir, paritaprevir, and ritonavir plus dasabuvir for 8 weeks in previously untreated patients with hepatitis C virus genotype 1b infection without cirrhosis (GARNET): a single-arm, open-label, phase 3b trialTania M Welzel, Tarik Asselah, Emily O Dumas, et al.
Gastroenterology|September 15, 2009
Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent mannerGolo Ahlenstiel, Rachel H Titerence, Christopher Koh, et al.
Scientific Reports|October 29, 2025
Novel and less invasive biomarker assays to measure liver ATP7B in Wilson disease patientsRosanna J Jiang, Lucy Chen, Kimberly Amburgey, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 27, 2019
Prevalence and predictors of complementary and alternative medicine modalities in patients with chronic hepatitis BKin Seng Liem, Colina Yim, Thomas D Ying, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 13, 2015
Hepatitis B Virus Screening for Patients With Cancer Before Therapy: American Society of Clinical Oncology Provisional Clinical Opinion UpdateJessica P Hwang, Mark R Somerfield, Devena E Alston-Johnson, et al.
Hepatology (Baltimore, Md.)|October 12, 2007
Hepatic gene expression during treatment with peginterferon and ribavirin: Identifying molecular pathways for treatment responseJordan J Feld, Santosh Nanda, Ying Huang, et al.
Virology Journal|February 26, 2016
Alanine aminotransferase, HCV RNA levels and pro-inflammatory and pro-fibrogenic cytokines/chemokines during acute hepatitis C virus infectionBehzad Hajarizadeh, François Mj Lamoury, Jordan J Feld, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 17, 2022
Characteristics of Older Patients With Immunotolerant Chronic Hepatitis B Virus InfectionJordan J Feld, Wendy C King, Marc G Ghany, et al.
Pageof 46